Aclaris Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aclaris Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2014 to Q2 2024.
  • Aclaris Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 71.3M shares, a 0.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 71.3M +563K +0.8% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 71.2M +4.04M +6.01% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 70.9M +4.21M +6.31% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 70.8M +4.14M +6.21% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 70.8M +4.1M +6.15% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 67.2M +5.47M +8.86% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 66.7M +5.46M +8.92% Dec 31, 2022 10-K 2024-02-27
Q3 2022 66.7M +5.45M +8.91% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 66.7M +5.46M +8.93% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 61.7M +9.66M +18.5% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 61.2M +16.1M +35.7% Dec 31, 2021 10-K 2023-02-23
Q3 2021 61.2M +18.3M +42.7% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 61.2M +18.5M +43.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 52.1M +10.2M +24.5% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 45.1M +3.62M +8.74% Dec 31, 2020 10-K 2022-02-24
Q3 2020 42.9M +1.54M +3.71% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 42.7M +1.41M +3.42% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 41.8M +563K +1.36% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 41.5M +275K +0.67% Dec 31, 2019 10-K 2021-02-25
Q3 2019 41.4M +10.4M +33.5% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 41.3M +10.3M +33.3% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 41.3M +10.4M +33.5% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 41.2M +10.4M +33.6% Dec 31, 2018 10-K 2020-02-25
Q3 2018 31M +156K +0.51% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 31M +4.23M +15.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 30.9M +4.81M +18.4% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 30.9M +4.8M +18.4% Dec 31, 2017 10-K 2019-03-18
Q3 2017 30.8M +9.41M +43.9% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 26.7M +5.33M +24.9% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 26.1M +5.78M +28.5% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 26.1M +5.9M +29.3% Dec 31, 2016 10-K 2018-03-12
Q3 2016 21.4M +18.7M +685% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 21.4M Jun 30, 2016 10-Q 2016-08-11
Q1 2016 20.3M Mar 31, 2016 10-Q 2016-05-11
Q4 2015 20.2M +17.4M +638% Dec 31, 2015 10-K 2017-03-15
Q3 2015 2.73M Sep 30, 2015 10-Q/A 2015-12-03
Q4 2014 2.73M Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.